Clinical Trial Update: Cholestanol in Humans [NA]

View source ↗

Summary

A clinical trial evaluating cholestanol in humans for Cerebrotendinous Xanthomatosis has been withdrawn. The sponsor is listed as the US Department of Veterans …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cerebrotendinous Xanthomatosis

Drugs mentioned

• Cholestanol (cholestanol)

Snippet

Sponsor: US Department of Veterans Affairs | Conditions: Cerebrotendinous Xanthomatosis | NA | Status: WITHDRAWN